- Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
-
Ahn YJ, Hwang HB, Chung SK
- KMID: 1792113
- Korean J Ophthalmol.
- 2014 Apr;28(2):177-180.
- doi: 10.3341/kjo.2014.28.2.177
Vascular endothelial growth factor inhibitor is an emerging therapeutic modality for various ocular diseases with neovascularization (NV). However, for corneal NV, controversy remains regarding whether bevacizumab or ranibizumab is superior.... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Bevacizumab on Corneal Neovascularization in Rabbits
-
Kim WJ, Jeong HO, Chung SK
- KMID: 949061
- Korean J Ophthalmol.
- 2010 Aug;24(4):230-236.
- doi: 10.3341/kjo.2010.24.4.230
PURPOSE: To determine the efficacy of topical application and subconjunctival injection of bevacizumab in the treatment of corneal neovascularization. METHODS: Corneal neovascularization was induced with a silk suture of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibition of corneal neovascularization by rapamycin
-
Kwon YS, Kim JC
- KMID: 1111410
- Exp Mol Med.
- 2006 Apr;38(2):173-179.
The purpose of this study was to determine whether rapamycin could inhibit corneal angiogenesis induced by basic fibroblast growth factor (bFGF). Using human dermal microvascular endothelial cells (HDMECs), we examined... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Bevacizumab versus Ranibizumab in the Treatment of Corneal Neovascularization: A Preliminary Study
-
Kim JH, Seo HW, Han HC, Lee JH, Choi SK, Lee D
- KMID: 1705418
- Korean J Ophthalmol.
- 2013 Aug;27(4):235-242.
- doi: 10.3341/kjo.2013.27.4.235
PURPOSE: To compare the short term effects of bevacizumab and ranibizumab injections on the regression of corneal neovascularization (NV). METHODS: Sixteen eyes of 16 patients with corneal NV were randomly assigned... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors Influencing the Prevalence of Amblyopia in Children with Anisometropia
-
Lee CE, Lee YC, Lee SY
- KMID: 949060
- Korean J Ophthalmol.
- 2010 Aug;24(4):225-229.
- doi: 10.3341/kjo.2010.24.4.225
PURPOSE: To evaluate factors that can influence the prevalence of amblyopia in children with anisometropia. METHODS: We retrospectively reviewed the records of 63 children 2 to 13 years of age... -
- CITED
-
- Close
- SHARE
-
- Close
